Dr. Chen Weijie Chairman of Lishan Biotech Firstly, we warmly welcome Dr. Du to Lishan. The comprehensive strategic cooperation between Lishan and Eglin is a new starting point, and we look forward to more achievements in the future. Firstly, I would like to ask Dr. Du how you view the live biopharmaceutical LBP industry? We have found that there are some large pharmaceutical companies in the United States, such as Nestle investing in Seres and Pfizer investing in Vedanta, and it seems that this industry is slowly starting to heat up. But I also heard some different voices, such as that its safety is acceptable, but its effectiveness and mechanism are very complex. What is your opinion on the live microbial medicine industry?   Dr. Du Tao Chairman of Eglin Pharmaceuticals Okay, I am Du Tao, the chairman of Eglin Pharmaceuticals in Shenzhen ...